Switching from semaglutide to tirzepatide is straightforward, but it is not a like-for-like dose swap. Because the two drugs have different potencies, the standard approach is to stop semaglutide, wait until your normal weekly injection day (about a week after your last dose), and start tirzepatide at the lowest dose — 2.5mg — no matter how high your semaglutide dose was. From there you titrate up every four weeks. Most people tolerate the switch well, and many switch specifically because tirzepatide produces more weight loss.
Important: this is general information, not medical advice. Your prescriber directs any change in medication, dose, or timing.
Switching to save money too? The cheapest way to get compounded tirzepatide from a licensed US telehealth provider is Embody at $119/month or Trimi at $125/month — both also carry semaglutide, so you can switch molecules without changing platforms. Compare every verified program on our best GLP-1 providers list.
Why people switch from semaglutide to tirzepatide
Three reasons come up again and again:
- You've plateaued. Weight loss on semaglutide naturally flattens over time. If you're at a therapeutic dose and the scale has stalled for several weeks, switching molecules is one of the evidence-based next steps — but first rule out the common plateau causes.
- You're a low responder. About 1 in 7 people don't get a strong response to semaglutide. Tirzepatide works on two gut-hormone receptors (GLP-1 *and* GIP) instead of one, which is why some people who stall on semaglutide respond better to it.
- You want more weight loss. In SURMOUNT-5, the first head-to-head trial, tirzepatide produced about 20% average body-weight loss versus about 14% for semaglutide over 72 weeks.
Tirzepatide isn't automatically "better" for everyone — semaglutide has more years of real-world data, an oral pill option (Rybelsus), and sometimes better insurance coverage. If you're still deciding, our tirzepatide vs semaglutide breakdown compares them head-to-head. This guide assumes you've already decided to switch.
Is there a semaglutide-to-tirzepatide dose conversion?
No — there is no 1:1 dose conversion between the two. They're different molecules on different milligram scales, so "I was on 1mg semaglutide, so I need X mg tirzepatide" doesn't work. The standard, guideline-aligned approach is to restart at the lowest tirzepatide dose (2.5mg weekly), regardless of your semaglutide dose, and titrate up from there.
Some prescribers will start a patient at 5mg instead of 2.5mg if they tolerated high-dose semaglutide with no real side effects — but that's a clinical judgment your prescriber makes, not something to self-adjust. Starting low protects you from stacking a more potent drug on a system that's still adjusting.
The switch, step by step
The goal is no gap in treatment and no overlap:
1. Take your last semaglutide dose on your normal day. 2. Wait about one week — until your next scheduled injection day. Published data shows switching within roughly 3–10 days of the last dose is well tolerated. 3. Start tirzepatide at 2.5mg on that day. 4. Hold each dose for at least 4 weeks before increasing, so your body adjusts to the higher potency.
You don't need to taper semaglutide first, and you shouldn't take both in the same week. If you're ever unsure about timing around a missed or late dose, ask your prescriber rather than doubling up.
Tirzepatide dose and titration schedule
Standard tirzepatide titration increases every 4 weeks. Your prescriber may move faster or slower based on how you tolerate each step:
| Weeks | Tirzepatide dose | Notes |
|---|---|---|
| 1–4 | 2.5mg | Starting dose for everyone switching — not a treatment dose |
| 5–8 | 5mg | First treatment-level dose |
| 9–12 | 7.5mg | Increase only if tolerating well |
| 13–16 | 10mg | Common maintenance range begins |
| 17–20 | 12.5mg | Escalate only if more response is needed |
| 21+ | 15mg | Maximum dose |
You do not have to reach 15mg. Many people find their "enough" dose at 5–10mg and stay there. There's no prize for rushing to the top.
What side effects to expect on the switch
Good news: switching from an existing GLP-1 is usually gentler than starting from scratch, because your gut is already used to this class of drug. A prospective study of people switching directly to tirzepatide found only about 13% had GI side effects and just ~2% stopped because of them.
The most common effects — nausea, and for many people constipation — tend to spike in the first few days after each dose *increase*, then settle. Practical ways people smooth the transition:
- Ask your prescriber to hold you at a dose longer if symptoms flare — slower titration is the single biggest lever.
- Smaller, lower-fat meals in the 48 hours after each shot.
- Stay ahead on fluids and electrolytes; tirzepatide slows digestion, so constipation is common.
- Flag anything severe — persistent vomiting, signs of dehydration, severe abdominal pain — to your prescriber. Don't push through it.
None of this is medical advice; your prescriber directs your dose and titration. It's just what the switch typically looks like.
The cost difference: semaglutide vs tirzepatide
Tirzepatide costs more than semaglutide at every tier — brand and compounded — because it's the newer, higher-demand molecule. Here's the current landscape:
| Option | Semaglutide | Tirzepatide |
|---|---|---|
| Brand (retail cash) | Ozempic / Wegovy ~$1,000–$1,350/mo | Mounjaro / Zepbound ~$1,000–$1,060/mo |
| Brand (manufacturer self-pay) | Wegovy ~$499/mo | Zepbound via LillyDirect ~$349/mo |
| Compounded (telehealth, cash) | ~$69–$99/mo | ~$119–$150/mo |
So budget for roughly $50/month more when you switch to compounded tirzepatide. The cheapest verified compounded tirzepatide we track is Embody at $119/month, then Trimi at $125/month. See the full ranked breakdown on the GLP-1 Price Index and our cheapest GLP-1 guide.
How to switch without a treatment gap or a new intake
This is the part most people get wrong. If your current provider only offers semaglutide, switching molecules means a whole new signup with a new provider. The fix:
- Pick a provider that carries both semaglutide and tirzepatide. Then switching is a message to your clinician, not a new intake. Embody, Trimi, and TrimRx all offer both molecules.
- Have your current prescription handy. A new provider will ask what you're on; a photo of your current label or prescription speeds approval.
- Remember your dose is in milligrams, not units. "60 units" only equals a specific mg amount at your current vial's concentration — a new pharmacy's vial may be a different concentration, so the number of units you draw can change even though the milligrams don't. Always go by the mg.
Switching back: tirzepatide to semaglutide
The same logic works in reverse. If tirzepatide's side effects or cost don't work for you, you can switch back — again restarting at a low semaglutide dose (typically 0.25mg) about a week after your last tirzepatide shot, and titrating up. Nothing about trying tirzepatide locks you in.
FAQ
Is there a direct semaglutide-to-tirzepatide dose conversion? No. There's no 1:1 equivalence. Regardless of your semaglutide dose, the standard approach is to restart tirzepatide at 2.5mg weekly and titrate up every 4 weeks. Some prescribers start at 5mg for people who tolerated high-dose semaglutide well — but that's their call.
How long should I wait between my last semaglutide dose and starting tirzepatide? About one week — your normal weekly injection day. Switching within roughly 3–10 days of your last semaglutide dose is well tolerated in published data. You should not take both in the same week.
Will switching to tirzepatide help me lose more weight? For many people, yes. In the SURMOUNT-5 head-to-head, tirzepatide produced about 20% body-weight loss versus about 14% for semaglutide. Individual results vary, and switching is most useful if you've genuinely plateaued at a therapeutic semaglutide dose.
Are the side effects worse when I switch? Usually milder than a fresh start, since your body is already used to the drug class. One study found only about 13% of people had GI side effects switching directly to tirzepatide. Nausea and constipation spike briefly after each dose increase, then settle.
How much more does tirzepatide cost than semaglutide? Roughly $50/month more for the compounded version — about $69–$99/mo for compounded semaglutide versus $119–$150/mo for compounded tirzepatide. See the GLP-1 Price Index for current provider pricing.
Do I need a new provider to switch? Only if your current one doesn't offer tirzepatide. Providers that carry both molecules — like Embody or Trimi — let you switch without a new intake.
The bottom line
Switching from semaglutide to tirzepatide is low-drama if you do it right: last semaglutide dose, wait about a week, restart tirzepatide at 2.5mg, and titrate up every 4 weeks under your prescriber's guidance. Expect milder side effects than your original start, budget about $50/month more for compounded tirzepatide, and — the biggest time-saver — pick a provider that carries both molecules so the switch is a message, not a new signup. Start with the lowest verified tirzepatide price at Embody ($119/mo), or compare every option on the best GLP-1 providers list.